29 May 2026
PBS wholesale mark-up fees Updated from July 1
The Pharmaceutical Benefits Scheme (PBS) has announced changes to wholesale mark-up (WMU) fees that will take effect from 1 July 2026 for medicines supplied through community pharmacies.
01 Jun 2026
PBS website updated with latest medicine and pricing changes
The Pharmaceutical Benefits Scheme (PBS) website has been updated with new information on medicine listings, pricing changes and administrative updates.
14 May 2026
Consultation opens on Australia’s national pharmacy workforce planning
The Pharmaceutical Society of Australia (PSA), in partnership with the University of Queensland, has opened a public consultation on the development of a national pharmacy workforce model.
13 May 2026
PBS to delist Zoladex 3.6 mg implant from November 2026
The Australian Government has announced that goserelin 3.6 mg implant (Zoladex Implant™) will be removed from the Pharmaceutical Benefits Scheme (PBS) from 1 November 2026.
08 May 2026
PBAC July 2026 Meeting Agenda Updated
The Pharmaceutical Benefits Advisory Committee (PBAC) has updated the agenda for its July 2026 meeting.
07 May 2026
PBAC releases April 2026 update on key health work
The Pharmaceutical Benefits Advisory Committee (PBAC) has released its April 2026 update, giving a summary of its recent work outside of its regular meeting schedule.
01 May 2026
PBS Website Updates and Changes – May 2026
The PBS website has been updated with new, amended and deleted items. A full list is available on the Summary of Changes page.
01 May 2026
PBS Update: Change to Glycopyrronium Cream Listing
From 1 June 2026, the PBS will update how one glycopyrronium cream item is described. This change only affects the wording, not the medicine itself.
01 May 2026
May 2026 PBAC meeting agenda now released
The agenda for the upcoming meeting of the Pharmaceutical Benefits Advisory Committee has now been published.
24 Apr 2026
Review completed on medicine stockholding rules in Australia
A 24-month review of Australia’s Minimum Stockholding Requirements for certain medicines has been finalised.